Testing a Behavioural Approach to Improving Cancer Screening Rates

March 21, 2018 updated by: Noah Ivers, Women's College Hospital

Testing a Behavioural Approach to Improving Cancer Screening Rates Through Increased Use of Primary Care Feedback Reports

Family doctors can play a critical role in successfully arranging cancer screening tests to occur, especially if they know which patients are due for these tests. However, they don't always interact with or take advantage of registry data to this end. For example, in Ontario, the Screening Activity Report provides exactly this information to family doctors, helping them identify their patients who are overdue for screening. Unfortunately, less than half of family doctors regularly use the Screening Activity Report even though they get monthly email reminders. One possible reason is that the reminders they receive are not designed to compel action. They are easy for family doctors to miss or dismiss. This study will compare multiple different ways of designing the reminders. The different versions of the email are tested in a 2^3 factorial trial testing three behaviour change techniques to see which ones will lead to more family physicians interacting with the Screening Activity Report and at increasing the number of patients that get all the appropriate screening tests for cervical, breast, and/or colon cancer.

Study Overview

Detailed Description

Screening is an important way to prevent cancer-related death, but many Ontarians do not receive guideline-recommended screening for cervical, breast, and colon cancer. Family physicians can play a critical role in successfully increasing screening rates. A recent evaluation by members of our team suggests that Screening Activity Report (SAR) use is associated with improved cancer screening, but there remains substantial room for improvement. For the SAR to reach its full potential to decrease cancer-related death by improving screening rates, family physicians must regularly access it and take the appropriate actions. Currently, family physicians receive monthly email reminders, which state that new data are available, but do not describe the benefits of the SAR for physicians or their patients. It is easy to imagine how a busy doctor would fail to act upon such emails, resulting in suboptimal use of the SAR and leading to avoidable delays in cancer screening, and management. Indeed, CCO data show that less than half of recipients attend to this email and <7% click through to the SAR. The objectives for this trial are to compare different versions of the reminders in a randomized trial to identify the features that most increase use of the SAR. This is a pragmatic, 2^3 factorial trial, comparing behaviour change techniques incorporated within email reminders to doctors increase their use of the SAR. Participants are those who are already sent monthly emails by CCO regarding the SAR. The trial will randomly assign participants to one of eight modified emails to determine which content is most effective at driving SAR-use over 4 months. With an expected sample size of over 5700 family physicians, we anticipate power to see differences of 3% across experimental conditions.

Study Type

Interventional

Enrollment (Actual)

5525

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G 2L7
        • Cancer Care Ontario

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Family physicians are eligible if they have signed up for the SAR and already receive reminder emails as part of their registration process for the SAR with CCO.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: FACTORIAL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: Email #1: FULLY TURNED OFF
No behavioural change techniques (BCTs) 'turned on' in the email. The email would contain only standardized content.
EXPERIMENTAL: Email #2: ANTICIPATED REGRET
Anticipated regret content + standardized content
Induce awareness of future regret about the unwanted behaviour
EXPERIMENTAL: Email #3: MATERIAL INCENTIVE
Material incentive content + standardized content
Inform that valued objects will be delivered if and only if that has been progress in performing the desired behaviours
EXPERIMENTAL: Email #4: PROBLEM SOLVING
Problem solving content + standardized content
Analyze or prompt the person to factors that influence the behaviour and select strategies that help overcome barriers
EXPERIMENTAL: Email #5: REGRET + INCENTIVE
Anticipated regret content + Material incentive content + standardized content
Induce awareness of future regret about the unwanted behaviour
Inform that valued objects will be delivered if and only if that has been progress in performing the desired behaviours
EXPERIMENTAL: Email #6: REGRET + PROBLEM SOLVING
Anticipated regret content + Problem solving content + standardized content
Induce awareness of future regret about the unwanted behaviour
Analyze or prompt the person to factors that influence the behaviour and select strategies that help overcome barriers
EXPERIMENTAL: Email #7: INCENTIVE + PROBLEM SOLVING
Material incentive content + Problem solving content + standardized content
Inform that valued objects will be delivered if and only if that has been progress in performing the desired behaviours
Analyze or prompt the person to factors that influence the behaviour and select strategies that help overcome barriers
EXPERIMENTAL: Email #8: ALL BCTs
Anticipated regret content + Material incentive content + Problem solving content + standardized content
Induce awareness of future regret about the unwanted behaviour
Inform that valued objects will be delivered if and only if that has been progress in performing the desired behaviours
Analyze or prompt the person to factors that influence the behaviour and select strategies that help overcome barriers

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SAR access
Time Frame: 4 months
The primary outcome will be whether eligible family physicians access the SAR during the 4 months of the trial (Yes/No)
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SAR access rate
Time Frame: 4 months
Number of times the SAR was accessed
4 months
Adherence to screening guidelines for breast, colon, and cervical cancer in patients of eligible PCPs
Time Frame: 4 months
Proportion of patients meeting screening guidelines for breast, colon, and cervical cancer; and efforts made by participants to access the SAR-use
4 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Process Measures: contact made with Cancer Care Ontario
Time Frame: 4 months
Number of calls to CCO contact centre regarding the SAR
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 10, 2017

Primary Completion (ACTUAL)

September 30, 2017

Study Completion (ACTUAL)

September 30, 2017

Study Registration Dates

First Submitted

April 18, 2017

First Submitted That Met QC Criteria

April 18, 2017

First Posted (ACTUAL)

April 21, 2017

Study Record Updates

Last Update Posted (ACTUAL)

March 22, 2018

Last Update Submitted That Met QC Criteria

March 21, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 2017-004-E

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Clinical Trial

Clinical Trials on Anticipated regret

Subscribe